PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company Reportsi3 Pharmaceuticals
i3 Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
RamelteonRamelteon2020-04-10
Sleep initiation and maintenance disorders
RanolazineRanolazine2022-04-272038
Angina pectoris
SelegilineSelegiline1997-04-01
Parkinson disease
,
Alzheimer disease
,
Schizophrenia
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
ZaroxolynMetolazone1982-01-01
Heart failure,
Hypertension,
Nephrotic syndrome,
Edema
Isosorbide hydralazineHydralazine, Isosorbide2024-01-17
Heart failure,
Pulmonary hypertension,
Malignant hypertension,
Hypertension,
Nephrotic syndrome,
Edema,
Dyskinesias,
Schizophrenia,
Coronary disease,
Angina pectoris,
Gastroesophageal reflux,
Diffuse esophageal spasm,
Poisoning,
Cyanosis
RifabutinRifabutin2026-03-192034-2042
Pulmonary tuberculosis,
Mycobacterium avium-intracellulare infection,
Mycobacterium infections,
Urinary tract infections,
Sinusitis,
Otitis media,
Gastroesophageal reflux,
Bacterial infections,
Bacterial skin diseases,
Soft tissue infections,
Chlamydia infections,
Helicobacter infections,
Stomach ulcer,
Duodenal ulcer,
Streptococcal infections,
Lyme disease,
Zollinger-ellison syndrome,
Listeriosis,
Esophagitis,
Heartburn,
Human bites,
Actinomycosis
Clinical Trials
No data
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use